Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News BioNTech SE BNTX

Healthcare Biotechnology
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142... see more

Current News (NDAQ:BNTX)

BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 2 days ago

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

GlobeNewswire December 18, 2025

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer

GlobeNewswire December 9, 2025

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

GlobeNewswire December 6, 2025

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

GlobeNewswire December 3, 2025

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

GlobeNewswire November 26, 2025

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

GlobeNewswire November 3, 2025

BioNTech to Host Innovation Series R&D Day on November 11, 2025

GlobeNewswire October 28, 2025

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

GlobeNewswire October 27, 2025
View More News ››

Opinion & Analysis (NDAQ:BNTX)

BioNTech & Cardiol Therapeutics – on the verge of a breakout

Stefan Feulner May 22, 2024

Takeover rumours: BioNTech, Cardiol Therapeutics and Novo Nordisk in focus

André Will-Laudien April 24, 2024

CureVac, BioNTech, Valeo Pharma: Where is there still potential?

Nico Popp October 16, 2020

BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results

Stockhouse Editorial September 29, 2020

BioNTech, CureVac, or Valeo Pharma: who brings the highest return to shareholders?

Stockhouse Editorial September 23, 2020

BioNTech, CureVac, EXMceuticals - reaching their goal with government support

Stockhouse Editorial September 18, 2020
View More Opinion ››

Bullboard Posts (NDAQ:BNTX)

Catastrophic Contagion 2025 - Mark the Date, and Be Ready!

if its what Bill Gates is into., podcast..  
petrojell - December 14, 2022

BioNTech Sees Vaccine Sales Push Q1 Revenues To €6.4 Billion

While many may view the pandemic as being over, the financial results of BioNTech  continue to say otherwise. The company...
AwareInvestor - May 9, 2022

BNTX to 500$? MUST video before it too late!

We don't make guesses but fact-based analysis. Check out and decide for yourself. Thank you:) https://www.youtube.com/watch?v...
latenightstocks - May 19, 2021

Biotech Top 5

What are your Top 5 Biotechs? 1. BioNTech 2. Bionano 3. Jaguar Health 4. Ocugen 5...perhaps the best one... WPD Pharmaceuticals (!?!)
Blocky - January 17, 2021

Bonvoyage12.....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on...
Mil_Man54 - December 26, 2020

Can the President Overrule the FDA on Vaccines?

An approval cycle that typically takes years is being expedited. In the case of the 2020 pandemic, the FDA  has shortened standard...
schoolofrock - October 7, 2020
View more Bullboard ››

NU E Power Corp

NU E Power Corp

NU E Power Corp. develops, owns, and operates renewable energy projects in Canada. It is involved in the development of solar ...
View More »

Podcasts